Caregen Co.Ltd Market Cap ($196.57 Million)
Market Cap & Net Worth: Caregen Co.Ltd (214370)
Caregen Co.Ltd market cap. Caregen Co.Ltd (KQ:214370) has a market capitalization of $196.57 Million (₩290.06 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #16408 globally and #600 in its home market, demonstrating a -19.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Caregen Co.Ltd's stock price ₩27000.00 by its total outstanding shares 10743000 (10.74 Million). Also see Caregen Co.Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Caregen Co.Ltd Market Cap History (2015–2026)
Caregen Co.Ltd market cap history from 2015 to 2026. Data shows growth from $117.99 Million to $196.57 Million (4.37% CAGR). Check 214370 live share price for real-time trading data and today's change.
Index Memberships
Caregen Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.10% | #206 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.10% | #206 of 1384 |
Weight: Caregen Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Caregen Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Caregen Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Caregen Co.Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Caregen Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Caregen Co.Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $117.99 Million | $36.42 Billion | $19.25 Billion | 0.00x | 0.01x |
| 2016 | $98.91 Million | $46.84 Billion | $22.96 Billion | 0.00x | 0.00x |
| 2017 | $104.99 Million | $57.89 Billion | $24.29 Billion | 0.00x | 0.00x |
| 2018 | $87.49 Million | $51.21 Billion | $16.49 Billion | 0.00x | 0.01x |
| 2019 | $94.40 Million | $64.70 Billion | $28.07 Billion | 0.00x | 0.00x |
| 2020 | $95.75 Million | $60.30 Billion | $31.48 Billion | 0.00x | 0.00x |
| 2021 | $91.93 Million | $59.09 Billion | $25.32 Billion | 0.00x | 0.00x |
| 2022 | $193.75 Million | $69.10 Billion | $27.27 Billion | 0.00x | 0.01x |
| 2023 | $198.15 Million | $79.21 Billion | $39.93 Billion | 0.00x | 0.00x |
| 2024 | $209.67 Million | $82.59 Billion | $32.31 Billion | 0.00x | 0.01x |
Competitor Companies of 214370 by Market Capitalization
Companies near Caregen Co.Ltd in the global market cap rankings as of November 4, 2026. Also see how large is Caregen Co.Ltd's balance sheet for a full breakdown of the balance sheet.
Key companies related to Caregen Co.Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5272 globally with a market cap of $2.49 Billion USD ( ₩3.67 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8989 globally with a market cap of $902.70 Million USD ( ₩1.33 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9557 globally with a market cap of $793.12 Million USD ( ₩1.17 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10371 globally with a market cap of $674.16 Million USD ( ₩994.80 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5272 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.49 Billion | ₩171400.00 |
| #8989 | ST Pharm Co.Ltd | KQ:237690 | $902.70 Million | ₩71400.00 |
| #9557 | NatureCell Co.Ltd | KQ:007390 | $793.12 Million | ₩22050.00 |
| #10371 | Oscotec Inc | KQ:039200 | $674.16 Million | ₩35400.00 |
Market Capitalization of Caregen Co.Ltd (2015–2026)
Market capitalization of Caregen Co.Ltd from 2015 to today. Between 2015 and today, Caregen Co.Ltd's market cap moved from $117.99 Million to $ 196.57 Million, with a yearly change of 4.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩196.57 Million | -62.40% |
| 2025 | ₩522.73 Million | +149.31% |
| 2024 | ₩209.67 Million | +5.82% |
| 2023 | ₩198.15 Million | +2.27% |
| 2022 | ₩193.75 Million | +110.75% |
| 2021 | ₩91.93 Million | -3.99% |
| 2020 | ₩95.75 Million | +1.43% |
| 2019 | ₩94.40 Million | +7.90% |
| 2018 | ₩87.49 Million | -16.66% |
| 2017 | ₩104.99 Million | +6.15% |
| 2016 | ₩98.91 Million | -16.18% |
| 2015 | ₩117.99 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Caregen Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $196.57 Million USD |
| MoneyControl | $196.57 Million USD |
| MarketWatch | $196.57 Million USD |
| marketcap.company | $196.57 Million USD |
| Reuters | $196.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Caregen Co.Ltd
Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands. It also provides medical devices under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG S… Read more